InvestSMART

Control Bionics Limited (ASX: CBL) - Announcements

- Current share price for CBL : $0.060

ASX company news and announcements for Control Bionics Limited (CBL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Control Bionics Limited (CBL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Control Bionics Limited (CBL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Control Bionics Limited (CBL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$33 Appendix 3B 4 Oct 2016 8:36AM $3.530 $0.060 fallen by 98.30%
$33 CBL Corporation completes Placement 30 Sep 2016 8:51AM $3.640 $0.060 fallen by 98.35%
$33 Share Purchase Acceptance Form 29 Sep 2016 8:47AM $3.640 $0.060 fallen by 98.35%
$33 Share Purchase Plan 29 Sep 2016 8:46AM $3.640 $0.060 fallen by 98.35%
$33 Cleansing Notice 29 Sep 2016 8:46AM $3.640 $0.060 fallen by 98.35%
$33 Investor Presentation 29 Sep 2016 8:45AM $3.640 $0.060 fallen by 98.35%
$33 CBL Corporation announces equity raising 29 Sep 2016 8:45AM $3.640 $0.060 fallen by 98.35%
$33 Trading Halt 29 Sep 2016 8:40AM $3.640 $0.060 fallen by 98.35%
$33 CBL converts to foreign exempt issuer on ASX 9 Sep 2016 7:34AM $3.150 $0.060 fallen by 98.10%
$33 Market Release - Change of ASX Admission Category 8 Sep 2016 5:44PM $3.150 $0.060 fallen by 98.10%
$33 ASX Notice - Change of ASX Admission Category 8 Sep 2016 5:30PM $3.150 $0.060 fallen by 98.10%
$33 CBL Corporation Limited 2016 Half Year Results 26 Aug 2016 7:44AM $2.650 $0.060 fallen by 97.74%
$33 CBL Half Year 2016 Results Briefing time change UPDATE 18 Aug 2016 7:31AM $2.590 $0.060 fallen by 97.68%
$33 CBL Corporation Half Year 2016 Results Briefing 15 Aug 2016 1:23PM $2.650 $0.060 fallen by 97.74%
$33 CBL RECEIVES APPROVAL TO REPAY A$ MEDIUM TERM NOTES EARLY 27 Jul 2016 8:57AM $2.700 $0.060 fallen by 97.78%
$33 CBL 2016 INTERIM ANNOUNCEMENT DATE 26 Jul 2016 6:31PM $2.700 $0.060 fallen by 97.78%
$33 CBL Seeks Right to Repay Current Debt Early 6 Jul 2016 8:52AM $2.600 $0.060 fallen by 97.69%
$33 SFS Update on EPS after Investor Call 1 Jul 2016 12:49PM $2.480 $0.060 fallen by 97.58%
$33 CBL Investor Presentation 30 Jun 2016 8:05AM $2.400 $0.060 fallen by 97.50%
$33 SFS Investor Briefing Updated Passcode 27 Jun 2016 10:07AM $2.300 $0.060 fallen by 97.39%
$33 Planned SFS Acquisition Investor Briefing 27 Jun 2016 8:04AM $2.350 $0.060 fallen by 97.45%
$33 CBL Corporation plans acquisition of SFS 23 Jun 2016 7:58AM $2.350 $0.060 fallen by 97.45%
$33 CBL Corporation Brexit Update 20 Jun 2016 12:04PM $2.350 $0.060 fallen by 97.45%
$33 CBL INSURANCE ACHIEVES RATING UPGRADE TO A- 10 Jun 2016 7:30AM $2.360 $0.060 fallen by 97.46%
$33 Results of Meeting 3 May 2016 12:37PM $2.160 $0.060 fallen by 97.22%

551 - 575 of 626 results

Page 23 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.